ICU antibiotic study reveals resistance risks
NCT ID NCT05171257
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined whether giving ICU patients the same antibiotic they had before, versus a different one, affects the development of drug-resistant bacteria. Researchers looked at 197 adults with Gram-negative infections. The goal was to understand how antibiotic choice impacts resistance, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM-NEGATIVE BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood cancer patients may need higher antibiotic doses to beat superbugs
- New antibiotic shows promise for newborns with dangerous infections
- New antibiotic shows promise for kids with tough infections
- New tetracycline drugs take on superbugs in Real-World trial
- New hope for kids with tough infections: experimental antibiotic combo tested